Information technology for detecting medication errors and adverse drug events by Anderson, James G
Purdue University
Purdue e-Pubs
RCHE Publications Regenstrief Center for Healthcare Engineering
8-17-2004
Information technology for detecting medication
errors and adverse drug events
James G. Anderson
Purdue University, andersonj@purdue.edu
Follow this and additional works at: http://docs.lib.purdue.edu/rche_rp
This document has been made available through Purdue e-Pubs, a service of the Purdue University Libraries. Please contact epubs@purdue.edu for
additional information.








2. Medication errors and adverse 
drug events
3. A systems approach to 
medication errors
4. Detection of adverse drug 
events using information 
technology
5. Expert opinion and conclusion
General
Information technology for 
detecting medication errors 
and adverse drug events
James G Anderson
Department of Sociology & Anthropology, Purdue University, West Lafayette, IN 47907, USA
It is estimated that over three-quarters of a million people are injured or die
in hospitals each year from adverse drug events (ADEs). The majority of med-
ical errors result from poorly designed healthcare systems rather than from
negligence on the part of healthcare providers. In general, healthcare sys-
tems rely on voluntary reporting, which seriously underestimates the number
of medication errors and ADEs by as much as 90%. This paper reviews the
causes and impact of medication errors and ADEs. It also reports studies that
have used information technology (IT) to detect and prevent medication
errors and ADEs. Significant reduction of medication errors and ADEs
requires systemic implementation of IT, improvements in the reporting of
errors, and integration of the components of the healthcare systems’ infor-
mation systems. At the present time, most healthcare systems should be able
to use IT to detect and prevent ADEs.
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1. Introduction
Studies dating back to 40 years ago indicate that a substantial number of patients
suffer adverse events while they are hospitalised [1-5]. Recently, the Institute of
Medicine (IOM) report [6] estimated that 44,000 – 98,000 hospitalised patients die
in the USA each year due to medical errors. Medical errors rank between the fourth
and seventh leading cause of death, exceeding deaths from automobile accidents,
AIDS and breast cancer.
Two studies of the incidence and types of adverse events occurring in US hospitals
in New York State, Utah and Colorado have reached similar conclusions. The
New York State study found that 3.7% of hospitalised patients suffered adverse
events [4]. Adverse events occurred in 2.9% of hospitalised patients in both Utah and
Colorado [7-8]. In New York State, 13.6% of the adverse events resulted in the
patient’s death; in Colorado and Utah, 8.8% of patients who suffered adverse events
died as a result. The Utah and Colorado study estimated that the total annual cost of
adverse events for these two states was $662 million, while the cost of preventable
adverse events was $308 million. For the nation as a whole, the total cost resulting
from preventable adverse events was estimated to be $17 – 29 billion per year.
Of the adverse events identified in the Utah and Colorado study, 45% resulted
from operative procedures. Drug errors accounted for 19% of adverse events. The
New York State study also found that drug-related errors accounted for 19% of
adverse events in hospitalised patients. Johnson and Bootman [9] estimated the
annual cost for the USA of morbidity and mortality due to drug therapy in 1995 to
be $76.6 billion.
This paper reviews the literature on: (1) the incidence and costs of medication
error-related adverse drug events (ADEs); (2) systems analyses of the causes of
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medication errors and ADEs; and (3) the use of informa-
tion technology (IT) to detect ADEs; and concludes that
tools are available to detect and reduce the number of
ADEs in healthcare settings. The following journals were
searched for articles on the use of IT to promote drug
safety: Journal of the American Medical Informatics Associa-
tion, International Journal of Medical Informatics, JAMA,
NEJM, Lancet, BMJ, Archives of Internal Medicine, and
Drug Safety, among others. 
2. Medication errors and adverse drug events
Not all medication errors result in ADEs. A study by Bates
et al. [10] found 530 medication errors out of 10,070 drug
orders. A total of 40 ADEs were detected. This translated into
∼ 1 ADE in 100 medication errors, while 7 in 100 errors had
the potential to cause an ADE.
In addition, medication-related errors that may result in
ADEs are frequent among hospitalised patients as well as
among out-patients. One study found preventable ADEs in
2 out of every 100 patients admitted to the hospital [11].
The study estimated that each ADE increased the cost of
hospitalisation by $4,700. For a 700-bed hospital, the
increased cost due to ADEs was estimated to be
$2.8 million annually or $2 billion for the USA as a whole.
A study of out-patients also found a rate of 5.5 ADEs per
100 patients who visited primary care physicians associated
with Brigham and Women’s Hospital in Boston due to
medication-related errors [12].
Determining the true rate of medication errors and
ADEs has been difficult since most errors are unreported.
One study focused on errors made during the dispensing
and administration stages of the drug delivery system [13].
The study found that the current method of collecting
data on the types and frequency of medication errors using
incident reports grossly underestimates errors. Only
36 errors were reported on incident reports and 84 errors
were reported on anonymous questionnaires. On the basis
of direct observation, the investigators estimated that
51,200 errors would have occurred in dispensing and
administering medications over a period of 59,470
patient-days. A second study was performed in an Army
out-patient pharmacy [14]. In this study, prescription errors
were separated from dispensing errors. The overall dis-
pensing error rate was 3.8%.
Manual chart review has been shown to be effective in
identifying medical errors and adverse events but is costly
[15]. However, direct observation can detect errors missed by
chart review. One study compared the use of retrospective
chart review to direct observation in detecting medication
errors [16]. Chart review estimated the error rate to be 0.2%.
In contrast, direct observation detected an error rate of 9.6%.
Detecting ADEs is also problematic. Most hospitals rely on
voluntary reporting of ADEs. This practice may result in the
detection and reporting of as few as 10% of ADEs [17-20].
3. A systems approach to medication errors
Traditional approaches to error detection and reduction in
healthcare have emphasised training, guidelines and sanctions.
Medical and nursing education focuses on knowledge and
adherence to protocols. Errors are treated as individual mis-
takes or failings and are punished largely by peer sanctions.
Ultimately, healthcare provider errors may be punished
through malpractice tort litigation [21].
At the same time there is growing awareness that the major-
ity of medical errors result from poorly designed healthcare
systems rather than primarily from negligence on the part of
healthcare providers. Preventing and reducing medical errors
and ADEs requires attention to the methods of detection used
and the prevention of errors at each stage of the delivery sys-
tem. Systemic modifications reduce the overall likelihood that
an error will occur and permit detection and intervention
before the error causes harm to a patient [22-26]. Several studies
have utilised a system approach to study medication errors.
This approach is much more likely to lead to improve-
ment in the detection and prevention of medication errors
that can lead to ADEs. For example, one study of ADEs
identified 16 causes of systems failure that resulted in medi-
cation errors that resulted in an ADE or had the potential to
result in an ADE [24]. The highest percentage of errors that
resulted in preventable ADEs was made during the ordering
stage (49%). Errors resulting in preventable ADEs were also
made at all other stages; transcription (6%), dispensing
(4%), and administration (34%) [27]. Of all the ADEs,
1% were fatal, 12% were life-threatening, 30% were serious,
and 57% were significant.
Failures in seven subsystems related to the delivery of medi-
cations accounted for 78% of the medication errors that
occurred. The most frequent system failures and resulted from
a lack of knowledge about drugs. A second major systems fail-
ure resulted from the unavailability of patient-specific infor-
mation at the time that the prescription was written. In a
number of instances the allergy defence system failed even
when information concerning patient allergies had been
included in the medical record. Manual transcription of phy-
sician orders was another major source of errors. Errors also
occurred because of the complexity of the system used to track
medications from ordering to administration.
This problem was compounded by problems in interservice
communication. Information about medication errors and
ADEs was not routinely provided to physicians, nurse and
pharmacists. As a result, there was little follow-up to prevent a
similar error from occurring again on hospital units.
The Institute for Safe Medication Practices [28] con-
ducted a national study of the ability of hospital pharmacy
systems to detect and prevent drug-related errors. The
investigators found that the pharmacy system only detected
about a third of these errors.
The inability of the pharmacy systems to detect errors was
primarily due to systems problems. Many hospital
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information systems are not integrated. Stand-alone systems
for order entry, pharmacy, and laboratories make it difficult to
detect medication errors that may result in ADEs. The lack of
integration also makes it difficult for providers to access drug
information as well as previous patient encounter information
at the time that drug orders are written. Moreover, many sys-
tems lack the capability to screen orders and alert or prompt
healthcare providers when dangerous situations that could
cause serious harm or death to a patient occur. Even within
the medication delivery system, the prescribing, dispensing
and administering stages in many instances were not electron-
ically linked. Futhermore, dispensing and administration
errors frequently occur when pharmacy systems use confusing
abbreviations and generate hard-to-read labels.
Studies such as the one reported above by the Institute for
Safe Medication Practices [28] suggest that piecemeal imple-
mentation of information systems may fail to detect and pre-
vent errors. Furthermore, physician order entry systems are
frequently complex and time-consuming. As a result, physi-
cians frequently bypass many of the systems and rely on
nurses, unit secretaries and pharmacists to enter orders into
the information systems.
Anderson and co-workers [29] developed a simulation
model to evaluate the capability of IT to detect and to prevent
ADEs in hospitals. The model was used to estimate ADE rates
and associated hospital costs based on five implementations of
IT. These were: provision of computer-based drug informa-
tion at the prescribing stage; physician computer order entry;
a unit dosing system in the pharmacy; an automated medica-
tion dispensing system; and a comprehensive information sys-
tem for medication delivery.
The model estimated that the various interventions, if indi-
vidually implemented, would reduce ADEs by 5 – 13%. The
largest reduction in errors and adverse events from a single
IT application would result from physician order entry. In
comparison, the implementation of a comprehensive infor-
mation system for medication delivery would result in a
28% reduction in ADEs. The estimated reduction in annual
hospital costs resulting from ADEs was estimated to range
$285,000 – $700,000 when IT was implemented piecemeal.
Implementation of a comprehensive information system was
estimated to save the hospital $1.5 million/year.
4. Detection of adverse drug events using 
information technology
As the use of IT to collect, store and transmit medical data
electronically becomes more widespread, this technology can
be used to identify ADEs. Bates and co-workers [30] review the
methodologies that use IT to detect adverse events in health-
care settings and studies that use these techniques. These tools
include the collection of clinical data in electronic form, event
monitoring and natural language processing. For example,
pharmacy data and clinical laboratory data are usually available
in coded electronic form. Also, these data are available in
real-time, permitting intervention in time to prevent ADEs
from harming patients. A number of studies have demon-
strated how these data can be screened for ADEs [31-38].
Basic information systems may be effective in identifying
and avoiding potential ADEs. One study classified hospital
information systems into three levels [39]. Level 1 systems
monitor medication orders for drug–drug interactions and
drug allergy problems. These systems require only that patient
demographics, results from diagnostic tests and current medi-
cations are available online. Level 2 systems, where all orders
are entered online by physicians, provide additional protec-
tion for patients through drug-dose checking, cumulative
dose checking, dose algorithms and detection of transcription
errors. More sophisticated Level 3 systems provide all of the
functional features of Level 1 and 2 systems as well as provid-
ing automated problem lists available online.
The study used chart reviews to identify adverse events
experienced by patients admitted to Brigham and Women’s
Hospital. The investigators estimated that 53% of adverse
events were identifiable with the lowest level information sys-
tem. A Level 2 system would have identified 58% of adverse
events and a Level 3 system, 89%. 
The more sophisticated systems are capable of detecting a
much larger percentage of ADEs and potential ADEs. For
example, a computerised system was developed at LDS Hos-
pital in Salt Lake City, Utah, to monitor ADEs [31]. The sys-
tem was programmed to generate a daily list of potential
ADEs from data contained in an integrated hospital informa-
tion system. Sudden medication stop orders, ordering of anti-
dotes, and abnormal laboratory values were taken as signs of
potential ADEs. A clinical pharmacist reviewed the medical
records of all patients on the list for potential ADEs. During
an 18-month period, 631 of 731 verified ADEs were detected
by the automated system. At the same time only 9 ADEs were
identified by the traditional reporting system.
Other investigators have developed and tested similar sys-
tems. Jha et al. [34] used a system based on the LDS hospital
rules to identify ADEs. The detection rules were based on
new medication orders, laboratory results above or below
threshold values, and medication orders associated with
changes in laboratory values. A daily list of alerts based on
these rules was generated by the computer system. Subse-
quently, the patient’s medical chart was reviewed for indica-
tion of an ADE or potential ADE.
The automated ADE detection system was compared to
two other strategies used to detect ADEs, chart review and
voluntary reporting. A total of 617 ADEs were detected by at
least one of the methods. The automated system detected
275 (45%) ADEs; chart review found 398 (65%) ADEs; and
voluntary reporting detected 23 (4% ADEs).
Most of the information systems used to detect ADEs have
been developed and implemented in in-patient hospital set-
tings. One system was developed to detect ADEs in an ambu-
latory setting [12]. Patient data from an electronic medical
record was used to detect ADEs. The computer system was
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programmed to search for ICD-9 codes that had been found to
be associated with ADEs. A database containing the patient’s
medication and drug allergy lists was also scanned. A third
approach to identifying ADEs was computer-event monitor-
ing. Rules were developed to identify new medication orders,
abnormal laboratory results and changes in laboratory values
that had a high probability of being associated with ADEs.
Finally, a data mining tool, Micromedex M2D2 medical data
dictionary, was used to electronically examine visit notes [40].
For each incident that was identified, a chart review was
used to ascertain whether or not an ADE had actually
occurred. The evaluation involved a period of 1 year and a
review of the electronic medical records for 23,064 patients. A
total of 864 ADEs were identified. Text searching identified
91% of the ADEs; 6% were identified from the allergy
records; event monitoring identified 3%; and ICD-9 codes
found only 0.3% of the ADEs.
5. Expert opinion and conclusion
According to the Joint Commission on Accreditation of
Healthcare Organisations (JCAHO), the medication error
rate is the most important indicator of the quality of the med-
ication delivery system. It is estimated that over three-quarters
of a million people are injured or die in hospitals annually
from ADEs [11,41]. National hospital expenditures resulting
from the treatment of persons injured by ADEs while hospi-
talised have been estimated to be as high as $5.6 billion per
year [8,11]. Between 1983 and 1993, deaths due to prescription
errors increased by 243% [42-43].
There is considerable evidence that medication errors that
result in ADEs can be detected and prevented [44]. Informa-
tion systems that include physician order entry, decision sup-
port, and alerting systems can significantly reduce errors and
adverse events that result in injury to or the death of patients.
For example, studies have demonstrated that computerised
physician order entry systems that include decision support
can significantly improve the quality of medication delivery
[101,45-47]. In addition, computerised alerting systems have
been shown to decrease error rates, delays in treatment, length
of hospital stay, and costs [48-51]. However, experience with
early hospital and ambulatory care medical information sys-
tems suggests that major organisational changes are frequently
required to successfully implement IT, especially physician
order entry systems [52,53].
However, in order to be effective, IT must be implemented
using a systems approach. Many hospitals lack an electronic
medical record that is needed to implement most decision sup-
port systems. Lack of integration of physician order entry sys-
tems, pharmacy systems, and laboratory systems is another
barrier to reducing medication errors.
As demonstrated by the simulation study [29], piecemeal
applications of IT have only limited results in reducing ADEs
and associated hospital costs. Moreover, it was estimated that
even the implementation of a comprehensive information
system for medication delivery would only reduce ADEs and
hospital costs by ∼ 28%. Computerised systems are only part
of the overall solution in preventing medication errors and
ADEs [54,55]. The process of reporting medication errors and
ADEs needs to be significantly improved. At present, only
∼ 10% of medication errors are reported using a voluntary
reporting system. Improvement in reporting will require a
system where persons reporting the error do not fear punish-
ment. Secondly, pharmacists need to be more directly inte-
grated into the medication delivery system at every stage.
Brigham and Women’s Hospital was able to reduce the ADE
rate in the ICU unit by two-thirds by having pharmacists
participate in patient rate with the intensive care unit team
[56]. This resulted in cost savings of $270,000/year. Finally,
nursing medication administration and monitoring systems
need to be improved. This should include bar-coding of
medications as well as improved labelling and warnings on
medications with a high potential for harm to patients.
To date, most applications of IT to identify and prevent
ADEs have focused on hospital in-patient settings. An
important area for future research is the development and
implementation of IT in ambulatory settings to identify and
prevent adverse drug reactions. Because of the high volume of
out-patient visits, IT has the potential to significantly
improve the quality of healthcare and reduce costs. A recent
report by the Center for Information Technology Leadership
[57] estimated the universal adoption of ambulatory compu-
terised provider order entry (ACPOE) systems that include
decision support would avoid 2.1 million ADEs, saving
$34 billion/year. However, it is estimated that < 10% of phy-
sicians in the US who practice in out-patient settings cur-
rently use any type of ACPOE.
There are significant barriers to the introduction of IT into
practice settings. At present, there are limited incentives for
providers to invest in IT in order to detect and prevent ADEs.
The Leapfrog Group, which consists of a number of Fortune
500 companies, strongly supports computer physician order
entry (CPOE) as a means of reducing medical errors, especially
errors that result in ADEs. In response, some payers are offering
financial incentives to healthcare providers who adopt CPOE. 
The President’s Information Technology Advisery Com-
mittee Draft Report [58] calls for accelerated adoption of IT
in the healthcare sector. They specifically recommend the
adoption of: (1) electronic health records to maximise the
information available to healthcare providers at the point of
care; (2) computer-assisted decision support to increase
compliance with evidence-based medicine; (2) electronic
order entry in both out-patient and in-patient practice set-
tings; and (4) interoperable electronic information inter-
change. In order to facilitate the implementation of these
recommendations, President Bush has proposed $100 mil-
lion to be spent on promising health IT.
The Centers for Medicare and Medicaid services have pro-
posed that computerised monitoring of ADEs be mandated in
in-patient settings [102]. While this is an important step in the
Anderson
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direction of improved patient safety, widespread adoption of
the IT applications to detect and prevent ADEs will require
both incentives and sanctions. Moreover, it will require a
change in the current ‘blame and shame’ culture that pervades
healthcare institutions at present [59]. 
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